Skip to contentH
Hims & Hers Health, Inc.
H
HIMSHims & Hers Health, Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$481.14M$481.14Mderived+95.1% vs Q4 2023 Net Income$26.03M$26.03Mderived+1,990.4% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Hims & Hers Health, Inc. · CIK 1773751 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$369,541,000+81.1% Operating Incomederived$18,596,000N/M Operating Cash Flowderived$86,385,000+293.0% Free Cash Flowderived$59,485,000— Margins · derivedGross margin76.8%−5.9 pt vs Q4 2023
Operating margin3.9%+4.0 pt vs Q4 2023
Net margin5.4%+4.9 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 24, 2025 · 55 d after period end